Pediatric Hypertension Clinical Presentation

  • Author: Edwin Rodriguez-Cruz, MD; more...
 
Updated: Dec 9, 2011
 

History

A well-taken history provides clues about the cause of hypertension and guides the selection and sequencing of ensuing investigations. Presenting symptoms and signs are not specific in neonates and are absent in most older children unless the hypertension is severe.

Relevant information includes the following:

  • History of umbilical artery catheterization
  • History of head or abdominal trauma
  • Family history of heritable diseases (eg, neurofibromatosis, hypertension)
  • Medications (eg, pressor substances, steroids, tricyclic antidepressants, cold remedies, medications for attention deficit hyperactivity disorder [ADHD])
  • Episodes of pyelonephritis (perhaps suggested by unexplained fevers) that may result in renal scarring
  • Dietary history, including caffeine, licorice, and salt consumption
  • Sleep history, especially snoring history
  • Habits, such as smoking, drinking alcohol, and ingesting illicit substances

Signs and symptoms that should alert the physician to the possibility of hypertension in neonates include the following:

  • Failure to thrive
  • Seizure
  • Irritability or lethargy
  • Respiratory distress
  • Congestive heart failure

Signs and symptoms that should alert the physician to the possibility of hypertension in older children include all of the above, as well as the following:

  • Headache
  • Fatigue
  • Blurred vision
  • Epistaxis
  • Bell palsy
Next

Physical Examination

Measurement and recording of blood pressure

Best medical care includes yearly measurement of blood pressure (BP) in every child older than 3 years, preferably by means of auscultation with a mercury gravity manometer. Doppler and oscillometric techniques can be used in children in whom auscultatory BP measurements are difficult to obtain. Measurements obtained with oscillometry that exceed the 90th percentile should be repeated with auscultation. Measurements repeated over time are required to obtain meaningful information.

Proper cuff size is essential for accurate measurement of BP. The width of the rubber bladder inside the cloth cover should cover at least 40% of the patient’s arm circumference at a point midway between the olecranon and the acromion. The length of the bladder in the cuff should cover 80-100% of the circumference of the arm. If a cuff is too small, the next larger cuff size should be used, even if it appears too large.

The child should be relaxed and in a comfortable, preferably sitting, position with the feet on the floor and the back supported. The patient’s right arm should be resting on a supportive surface at the level of the heart. Infants can be examined while supine.

The cuff should be inflated at a pressure approximately 20 mm greater than that at which the radial pulse disappears, then allowed to deflate at a rate of 2-3 mm Hg/s.

The first Korotkoff sound (ie, appearance of a clear tapping sound) defines the systolic pressure, whereas the fifth Korotkoff sound (ie, disappearance of all sounds) defines the diastolic pressure. The fourth (low-pitched, muffled) sound and the fifth sound frequently occur simultaneously, or the fifth sound may not occur at all. Diastolic BP must be recorded. When Korotkoff sounds can be heard down to 0 mm Hg, the BP measurement should be repeated with less pressure applied to the head of the stethoscope than was applied before.

Systolic BP in the lower extremities must be measured when elevated systolic BP in the upper extremities is first noted, regardless of whether the amplitude of the arterial pulse seems lower in the legs than in the arms. Increased systolic pressure in the arm suggests coarctation of the aorta. If found, systolic pressure must also be measured in the left arm and leg.

With the patient in the supine position, place a cuff on the calf. The cuff should be wide enough to cover at least two thirds of the distance from knee to ankle. Doppler sonography can be used to detect onset of blood flow, which reflects systolic BP, in the posterior tibial or dorsalis pedis artery. The value should be compared with a similarly obtained Doppler systolic BP in the arm, again with the patient supine.

Remember that the artifact of distal pulse amplification causes the measured systolic BP at the brachial artery to be less than that at the posterior tibial or dorsalis pedis artery. This difference may be only a few millimeters of mercury in the infant but can rise to 10-20 mm Hg in the older child or adult. The magnitude of this artifact is directly proportional to the pulse pressure. In a patient with chronic aortic regurgitation, for example, the difference in measured systolic pressure may exceed 40 mm Hg.

At no time should the systolic pressure in the arm exceed that in the foot. If it does, pressures in both arms and legs should be measured. Consistent recording of high arm systolic pressure indicates aortic coarctation. High pressure in only the right arm suggests that an obstruction is present proximal to the origin of the left subclavian artery.

Interpretation of blood pressure values

Hypertension is defined as an average systolic or diastolic BP above the 95th percentile. Any child with a BP exceeding the 90th percentile requires scrutiny.

Patients with severe hypertension and target-organ damage require immediate attention. For other patients, several measurements of BP should be made at weekly intervals to determine if the elevation is sustained.

The average of multiple measurements should be plotted on an appropriate percentile chart. If the average measurement is between the 90th and 95th percentiles (ie, the patient is prehypertensive) the child’s BP should be monitored at 6-month intervals. If the average BP is greater than the 95th percentile, the child should be evaluated further and therapy considered.

Patients with stage I hypertension should be seen again in 1-2 weeks. Those with stage II hypertension should be reevaluated in 1 week or sooner if the patient is symptomatic.

So-called white-coat hypertension is diagnosed in a patient who has a BP above the 95th percentile when measured in the physician’s office but who is normotensive outside the clinical setting. Ambulatory monitoring of BP usually is required to diagnose white-coat hypertension.

Identification of signs of secondary hypertension

A primary objective of the physical examination is to identify signs of secondary hypertension. The following should be evaluated to assess for potential causes of the hypertension:

  • Body mass index, to assess for metabolic syndrome
  • Tachycardia, to assess for hyperthyroidism, pheochromocytoma, and neuroblastoma
  • Growth retardation, to assess for chronic renal failure
  • Café au lait spots, to assess for neurofibromatosis
  • Abdominal mass, to assess for Wilms tumor and polycystic kidney disease
  • Epigastric or abdominal bruit, to assess for coarctation of the abdominal aorta or renal artery stenosis
  • BP difference between upper and lower extremities, to assess for coarctation of the thoracic aorta
  • Thyromegaly, to assess for hyperthyroidism
  • Virilization or ambiguity, to assess for adrenal hyperplasia
  • Stigmata of Bardet-Biedl, von Hippel-Lindau, Williams, or Turner syndromes
  • Acanthosis nigricans, to assess for metabolic syndrome
Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Edwin Rodriguez-Cruz, MD  Assistant Professor, Department of Pediatrics, San Juan Bautista Medical School and Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Pediatrics, Hospital El Maestro and San Juan Bautista Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Cardiology, Cardiovascular Center of Puerto Rico and the Caribbean and Veterans Affairs Hospital and Medical Center of Puerto Rico

Edwin Rodriguez-Cruz, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Medical Association, American Society of Echocardiography, Puerto Rico Medical Association, Society of Cardiac Angiography and Interventions, and Society of Pediatric Echocardiography

Disclosure: NOVARTIS Grant/research funds INVESTIGATOR

Additional Contributors

Leigh M Ettinger, MD, MS Clinical Assistant Professor, Division of Pediatric Nephrology, The Joseph M Sanzari Children's Hospital, Hackensack University Medical Center

Disclosure: Nothing to disclose.

Ira H Gessner, MD Professor Emeritus, Pediatric Cardiology, University of Florida College of Medicine

Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

John W Moore, MD, MPH Professor of Clinical Pediatrics, Section of Pediatric Cardiology, Department of Pediatrics, University of California San Diego School of Medicine; Director of Cardiology, Rady Children's Hospital

John W Moore, MD, MPH is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Adrian Spitzer, MD Clinical Professor Emeritus, Department of Pediatrics, Albert Einstein College of Medicine

Adrian Spitzer, MD is a member of the following medical societies: American Academy of Pediatrics, American Federation for Medical Research, American Pediatric Society, American Society of Nephrology, American Society of Pediatric Nephrology, International Society of Nephrology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. [Guideline] Task Force. Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics. Jan 1987;79(1):1-25. [Medline].

  2. [Guideline] Task Force. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control. Pediatrics. Oct 1996;98(4 Pt 1):649-58. [Medline].

  3. [Guideline] NHLBI. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. Aug 2004;114(2 Suppl 4th Report):555-76. [Medline]. [Full Text].

  4. Gruskin AB. Factors affecting blood pressure. In: Drukker A, Gruskin AB, eds. Pediatric Nephrology: Pediatric and Adolescent Medicine. 3rd ed. Basel, Switzerland: Karger; 1995:1097.

  5. Gavrilovici C, Boiculese LV, Brumariu O, Dimitriu AG. [Etiology and blood pressure patterns in secondary hypertension in children]. Rev Med Chir Soc Med Nat Iasi. Jan-Mar 2007;111(1):70-81. [Medline].

  6. Kapur G, Ahmed M, Pan C, Mitsnefes M, Chiang M, Mattoo TK. Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report. J Clin Hypertens (Greenwich). Jan 2010;12(1):34-9. [Medline].

  7. Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. Feb 2004;113(2):328-33. [Medline].

  8. Leung LC, Sung RY, So HK, et al. Prevalence and risk factors for hypertension in Hong Kong Chinese adolescents: waist circumference predicts hypertension, exercise decreases risk. Arch Dis Child. Sep 2011;96(9):804-9. [Medline].

  9. [Guideline] University of Michigan Health System. Essential hypertension. Ann Arbor (MI): University of Michigan Health System; 2009 Feb. [Full Text].

  10. Meyers RS, Siu A. Pharmacotherapy Review of Chronic Pediatric Hypertension. Clin Ther. Oct 7 2011;[Medline].

  11. Schaefer F, Litwin M, Zachwieja J, Zurowska A, Turi S, Grosso A, et al. Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens. Oct 21 2011;[Medline].

  12. Aeberli I, Spinas GA, Lehmann R, l'Allemand D, Molinari L, Zimmermann MB. Diet determines features of the metabolic syndrome in 6- to 14-year-old children. Int J Vitam Nutr Res. Jan 2009;79(1):14-23. [Medline].

  13. Gonzalez-Juanatey JR, Paz FL, Eiras S, Teijeira-Fernandez E. [Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations]. Rev Esp Cardiol. Jun 2009;62 Suppl 2:9-16. [Medline].

  14. Kshatriya S, Reams GP, Spear RM, Freeman RH, Dietz JR, Villarreal D. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis. Curr Opin Nephrol Hypertens. Oct 21 2009;[Medline].

  15. Nakamura Y, Ueshima H, Okuda N, et al. Relation of serum leptin to blood pressure of Japanese in Japan and Japanese-Americans in Hawaii. Hypertension. Dec 2009;54(6):1416-22. [Medline].

Previous
Next
 
Management algorithm. AMC = Apparent mineralocorticoid excess; GRA = Glucocorticoid remedial aldosteronism; VMA = Vanillylmandelic acid.
Table 1. Ninety-Fifth Blood Pressure Percentiles for 50th and 75th Height Percentiles in Children and Adolescents[3]
Age, y 95th BP Percentile for Girls, mm Hg 95th BP Percentile for Boys, mm Hg
50th Height Percentile 75th Height Percentile 50th Height Percentile 75th Height Percentile
1104/58105/59103/56104/58
6111/74113/74114/74115/75
12123/80124/81123/81125/82
17129/84130/85136/87138/87
Table 2. Common Causes of Hypertension by Age
Infants Children Adolescents
1-6 y 7-12 y
Thrombosis of renal artery or vein



Congenital renal anomalies



Coarctation of aorta



Bronchopulmonary dysplasia



Renal artery stenosis



Renal parenchymal disease



Wilms tumor



Neuroblastoma



Coarctation of aorta



Renal parenchymal disease



Renovascular abnormalities



Endocrine causes



Essential hypertension



Essential hypertension



Renal parenchymal disease



Endocrine causes



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.